BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8962277)

  • 21. [Monoclonal antibodies in organ transplantation].
    Vanhove B
    Med Sci (Paris); 2009 Dec; 25(12):1121-5. PubMed ID: 20035690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive effects of anti-CD3 MAb and soluble co-stimulatory molecules.
    Bluestone JA; Bruce D; Peterson L; Thistlethwaite JR; Josephson M; Zeng Y; Linsley PS; Lenschow DJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):546-7. PubMed ID: 8438407
    [No Abstract]   [Full Text] [Related]  

  • 23. Rationale for OKT3 monoclonal antibody treatment in transplant patients.
    Norman DJ
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):1-3. PubMed ID: 8465414
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical development of Orthoclone OKT3.
    Cosimi AB
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):7-16. PubMed ID: 3105142
    [No Abstract]   [Full Text] [Related]  

  • 25. Biological reagents for immunosuppressants.
    Soulillou JP
    Transplant Proc; 1995 Feb; 27(1):106-8. PubMed ID: 7878803
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of antilymphocyte induction therapy in liver transplantation: A European perspective.
    Langrehr JM; Neuhaus PJ
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S71-84. PubMed ID: 10431020
    [No Abstract]   [Full Text] [Related]  

  • 27. The clinical role of OKT3.
    Norman DJ
    Cardiol Clin; 1990 Feb; 8(1):97-105. PubMed ID: 2407364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies as targeting and therapeutic agents: prospects for liver transplantation, hepatitis and hepatocellular carcinoma.
    Luk JM; Wong KF
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):482-8. PubMed ID: 16700883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can treatment with the monoclonal antibody BMA031 induce cytokine release?
    Zlabinger GJ; Pohanka E; Stuhlmeier KM; Eher R; Schmaldienst S; Watschinger B; Steiner G; Kovarik J
    Transplant Proc; 1992 Feb; 24(1):271-2. PubMed ID: 1539278
    [No Abstract]   [Full Text] [Related]  

  • 31. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
    Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
    Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A U.S. clinical study of Orthoclone OKT3 in renal transplantation.
    Norman DJ; Shield CF; Barry J; Henell K; Funnell MB; Lemon J
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):21-7. PubMed ID: 3105136
    [No Abstract]   [Full Text] [Related]  

  • 33. Biological immunosuppressants: the way to clinical transplantation tolerance.
    Chatenoud L
    Transplant Proc; 1997; 29(1-2):51-5. PubMed ID: 9123108
    [No Abstract]   [Full Text] [Related]  

  • 34. Transplantation across previously incompatible immunological barriers.
    Magee CC
    Transpl Int; 2006 Feb; 19(2):87-97. PubMed ID: 16441356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anergic cells generated in vitro suppress rejection response to islet allografts.
    Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
    Transplant Proc; 1999; 31(1-2):623. PubMed ID: 10083265
    [No Abstract]   [Full Text] [Related]  

  • 36. Antilymphocyte globulins in kidney transplantation.
    Kreis H
    Kidney Int Suppl; 1992 Oct; 38():S188-92. PubMed ID: 1405373
    [No Abstract]   [Full Text] [Related]  

  • 37. Case 6: benefits and risks of OKT3 treatment in renal transplantation.
    First MR
    Transplantation; 2001 Sep; 72(6):1177-8. PubMed ID: 11584824
    [No Abstract]   [Full Text] [Related]  

  • 38. [Is it possible to zero the immune system? Co-stimulatory blockade: experimental studies to achieve transplantation tolerance].
    Aasvang EK; Egfjord M
    Ugeskr Laeger; 2003 Apr; 165(15):1562-5. PubMed ID: 12715660
    [No Abstract]   [Full Text] [Related]  

  • 39. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunology. Gently soothing a savage immune system.
    Couzin J
    Science; 2002 Apr; 296(5567):456-8. PubMed ID: 11964457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.